JAMES ALEXANDER

MA (Cantab.) MBBS PhD MRCP

James is the Freed Foundation IBD Lecturer and a Gastroenterology Specialist Registrar at Imperial College London and Imperial Healthcare NHS Trust. He completed his undergraduate medical degree at the University of Cambridge, before moving to Imperial College for clinical studies, where he was awarded a series of merits and won the John Adamson prize in his finals examinations.

He was awarded his PhD in 2019 for research on the role of the gut microbiome in Colorectal Cancer (CRC), under the supervision of Professors Julian Teare, Julian Marchesi, and Dr James Kinross. Funded by funded by Bowel and Cancer Research, Imperial College and the Royal Marsden NIHR Biomedical Research Centres, his work employs computational and systems biology approaches, encompassing metataxonomics and metabolomics. He was also part of the team developing a novel endoscopic approach to colorectal lesion recognition using Rapid evaporative ionisation mass spectrometry (REIMS), for which he was recognised with the Gerald Marks Cancer Award by the Society of American Gastrointestinal and Endoscopic Surgeons.

James is continuing his translational research in inflammatory bowel disease and cancer in the Powell Lab. He is the first author on the 2021 British Society of Gastroenterology IBD section position statement on SARS-CoV-2 vaccination for patients with IBD.

For full publication list see: https://www.imperial.ac.uk/people/j.alexander